Signal2026-06-04
ClinicalTrials.gov

[PHASE4] Pilot Deprescribing of Antimuscarinic Overactive Bladder Medications in Parkinson Disease

Part of

Behavioral Pharmacology And Drug Effects

Open primary sourceSee the whole picture